BOT 3.80% 38.0¢ botanix pharmaceuticals ltd

Ann: Final Sofdra Labelling Discussions with FDA, page-216

  1. 1,774 Posts.
    lightbulb Created with Sketch. 1173
    "...there is a premium already priced into this stock..."

    Agreed - it is entirely possible professional investment firms such as Euroz Hartley and E&P are way off on their predicted prices (shared in May '24), perhaps even missing their grip on reality like the average punter, and expecting the market to be forward looking which of course it isn't:

    E&P:
    https://hotcopper.com.au/data/attachments/6253/6253599-47c81544fb4adc195b3e6ac15e98d3db.jpg

    Hartleys:
    https://hotcopper.com.au/data/attachments/6253/6253592-6027b6c4a6783acf65dc7cb8222b20a5.jpg

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
-0.015(3.80%)
Mkt cap ! $687.8M
Open High Low Value Volume
39.0¢ 39.0¢ 37.5¢ $3.489M 9.104M

Buyers (Bids)

No. Vol. Price($)
10 893523 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 159482 2
View Market Depth
Last trade - 16.10pm 18/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.